Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Free Cash Flow (2021 - 2025)

Zymeworks' Free Cash Flow history spans 5 years, with the latest figure at -$10.8 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 72.79% to -$10.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$34.5 million, a 68.63% increase, with the full-year FY2025 number at -$34.5 million, up 68.63% from a year prior.
  • Free Cash Flow hit -$10.8 million in Q4 2025 for Zymeworks, up from -$31.8 million in the prior quarter.
  • Over the last five years, Free Cash Flow for ZYME hit a ceiling of $334.2 million in Q4 2022 and a floor of -$83.6 million in Q1 2023.
  • Historically, Free Cash Flow has averaged -$10.0 million across 5 years, with a median of -$31.8 million in 2025.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 757.97% in 2022 and later tumbled 369.42% in 2025.
  • Tracing ZYME's Free Cash Flow over 5 years: stood at -$50.8 million in 2021, then skyrocketed by 757.97% to $334.2 million in 2022, then tumbled by 95.55% to $14.9 million in 2023, then plummeted by 367.62% to -$39.8 million in 2024, then skyrocketed by 72.79% to -$10.8 million in 2025.
  • Business Quant data shows Free Cash Flow for ZYME at -$10.8 million in Q4 2025, -$31.8 million in Q3 2025, and $11.6 million in Q2 2025.